BIENAIME JEAN JACQUES

CIK 000122159010 companiesSAN MATEO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001221590

Recent Transactions

50 trades

Award
INCYTE CORP$INCY
Common Stock
2025-06-10+2,518→ 20,841 total
Award
Immunome Inc.$IMNM
Director Stock Option (right to buy)
2025-06-10+18,864→ 18,864 total
Award
INCYTE CORP$INCY
Non Qualfied Stock Option (right to buy)
2025-06-10+9,216→ 9,216 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2025-06-04+10,500→ 10,500 total
Award
Keros Therapeutics, Inc.$KROS
Common Stock
2025-06-04+5,250→ 5,450 total
Purchase
Immunome Inc.$IMNM
Common Stock
2025-06-03$9.38/sh+5,000→ 36,415 total
Purchase
Immunome Inc.$IMNM
Common Stock
2025-03-25$7.78/sh+7,800→ 31,415 total
Purchase
Immunome Inc.$IMNM
Common Stock
2025-03-24$8.21/sh+7,000→ 23,615 total
Purchase
Immunome Inc.$IMNM
Common Stock
2024-08-16$13.94/sh+7,000→ 16,615 total
Award
Immunome Inc.$IMNM
Stock option (right to buy)
2024-06-13+11,333→ 11,333 total
Award
INCYTE CORP$INCY
Common Stock
2024-06-12+2,830→ 18,323 total
Award
INCYTE CORP$INCY
Non Qualfied Stock Option (right to buy)
2024-06-12+12,517→ 12,517 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2024-06-03+17,600→ 17,600 total
Purchase
Immunome Inc.$IMNM
Common Stock
2024-05-21$13.57/sh+2,000→ 9,615 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-20$77.05/sh−1,202→ 473,792 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-10$81.14/sh−20,000→ 474,994 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-10$63.10/sh+20,000→ 494,994 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-05-10−20,000→ 51,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-09$63.10/sh+20,000→ 494,994 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-09$81.62/sh−20,000→ 474,994 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-05-09−20,000→ 71,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-04-12−20,000→ 91,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-04-12$63.10/sh+20,000→ 494,994 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-04-12$91.26/sh−20,000→ 474,994 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-04-11−20,000→ 111,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-04-11$63.10/sh+20,000→ 494,994 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-04-11$90.99/sh−20,000→ 474,994 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-03-15$83.87/sh−85,209→ 474,994 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-03-06$86.71/sh−1,000→ 560,203 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-03-05$85.51/sh−1,000→ 561,203 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-02-27+24,926→ 563,203 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-02-27+82,700→ 502,302 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-02-27$90.35/sh−1,000→ 562,203 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-02-27+35,975→ 538,277 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-02-09$88.28/sh−15,000→ 419,602 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-02-09$63.10/sh+15,000→ 434,602 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-02-09−15,000→ 131,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-02-08$63.10/sh+15,000→ 434,602 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-02-08$89.77/sh−15,000→ 419,602 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-02-08−15,000→ 146,000 total
Small Acquisition
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-01-18$92.60/sh+40→ 419,602 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-01-10−10,000→ 161,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-01-10$63.10/sh+10,000→ 435,162 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-01-10$96.38/sh−10,000→ 425,162 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-01-09$63.10/sh+10,000→ 435,162 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-01-09−10,000→ 171,000 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-01-09$98.19/sh−10,000→ 425,162 total
Small Acquisition
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-01-08$99.05/sh+50→ 425,162 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2023-12-21$93.99/sh−10,000→ 425,112 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2023-12-21−10,000→ 181,000 total

Companies

Recent Filings

Address

C/O NEUROGESX, INC. 2215 BRIDGEPOINTE PARKWAY, SUITE 200

SAN MATEO, CA, 94404

View on SEC.gov